Ultrasmall, elementary and highly translational nanoparticle X-ray contrast media from amphiphilic iodinated statistical copolymers

To expand the single-dose duration over which noninvasive clinical and preclinical cancer imaging can be conducted with high sensitivity, and well-defined spatial and temporal resolutions, a facile strategy to prepare ultrasmall nanoparticulate X-ray contrast media (nano-XRCM) as dual-modality imaging agents for positron emission tomography (PET) and computed tomography (CT) has been established. Synthesized from controlled copolymerization of triiodobenzoyl ethyl acrylate and oligo(ethylene oxide) acrylate monomers, the amphiphilic statistical iodocopolymers (ICPs) could directly dissolve in water to afford thermodynamically stable solutions with high aqueous iodine concentrations (>140 mg iodine/mL water) and comparable viscosities to conventional small molecule XRCM. The formation of ultrasmall iodinated nanoparticles with hydrodynamic diameters of ca. 10 nm in water was confirmed by dynamic and static light scattering techniques. In a breast cancer mouse model, in vivo biodistribution studies revealed that the 64Cu-chelator-functionalized iodinated nano-XRCM exhibited extended blood residency and higher tumor accumulation compared to typical small molecule imaging agents. PET/CT imaging of tumor over 3 days showed good correlation between PET and CT signals, while CT imaging allowed continuous observation of tumor retention even after 10 days post-injection, enabling longitudinal monitoring of tumor retention for imaging or potentially therapeutic effect after a single administration of nano-XRCM.

Preparation and characterization of dasatinib albumin micelles / 中国药科大学学报

@#In this study, a polyethylene glycol and dodecaldehyde modified bovine serum albumin (PEG-DSA) was developed, and its feasibility as a new high-efficiency micellar carrier for dasatinib (DAS) was explored.Circular dichroism, 1H NMR, elemental analysis, FT-IR and other methods were used to characterize the material structure and the single factor method was used to optimize the process of PEG-DSA/DAS micelles and non-PEGylated control micelles DSA/DAS.The results indicated that the optimal formulation was obtained with a mass ratio of 4∶1 between PEG-DSA and DAS, with average particle size of (37.21 ± 0.21) nm, polydispersion index (PDI) of (0.24 ± 0.04), Zeta potential of ? (15.68 ± 0.19) mV, drug loading (DL) capacity of (10.22 ± 0.34) %, and encapsulation efficiency (EE) of (42.73 ± 1.15) %. Compared with the currently reported nano-formulations of DAS, the drug loading of PEG-DSA/DAS micellar formulations was significantly increased with potential for further development.

Development of fluorescent- and radio-traceable T1307-polymeric micelles as biomedical agents for cancer diagnosis: biodistribution on 4T1 tumor-bearing mice

Abstract In recent years, nanocarriers have been studied as promising pharmaceutical tools for controlled drug-delivery, treatment-efficacy follow-up and disease imaging. Among them, X-shaped amphiphilic polymeric micelles (Tetronic®, poloxamines) display great potential due to their biocompatibility and non-toxic effects, among others. In the present work, polymeric micelles based on the T1307 copolymer were initially decorated with a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-fluorophore in order to determinate its in vivo biodistribution on 4T1 tumor-bearing mice. However, unfavorable results with this probe led to two different strategies. On the one hand, the BODIPY-micelle-loaded, L-T1307-BODIPY, and on the other hand, the 99mTc-micelle-radiolabeled, L-T1307- 99m Tc, were analyzed separately in vivo. The results indicated that T1307 accumulates mainly in the stomach, the kidneys, the lungs and the tumor, reaching the maximum organ-accumulation 2 hours after intravenous injection. Additionally, and according to the results obtained for L-T1307- 99m Tc, the capture of the polymeric micelles in organs could be observed up to 24 hours after injection. The results obtained in this work were promising towards the development of new radiotracer agents for breast cancer based on X-shaped polymeric micelles.

Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers

The beneficial or deleterious effects of nanomedicines emerge from their complex interactions with intracellular pathways and their subcellular fate. Moreover, the dynamic nature of plasma membrane accounts for the movement of these nanocarriers within the cell towards different organelles thereby not only influencing their pharmacokinetic and pharmacodynamic properties but also bioavailability, therapeutic efficacy and toxicity. Therefore, an in-depth understanding of underlying parameters controlling nanocarrier endocytosis and intracellular fate is essential. In order to direct nanoparticles towards specific sub-cellular organelles the physicochemical attributes of nanocarriers can be manipulated. These include particle size, shape and surface charge/chemistry. Restricting the particle size of nanocarriers below 200 nm contributes to internalization

Biosurfactant and bioemulsifier as promising molecules produced by Mucor hiemalis isolated from Caatinga soil

BACKGROUND: The present study describes the production of biosurfactant (BS) and emulsifier (BE) by the filamentous fungus Mucor hiemalis UCP 0039, as well as the characterization and stability of the both biomolecules for environmental or industrial applications. RESULTS: Biosurfactants and bioemulsifiers are amphiphilic compounds and are produced as extracellular molecules. The results showed that bioproduct obtained by shaker condition reduced the water surface tension of 72 to 32 mN/m and reached an emulsification index of 96%, while the static cultivation resulted in a biomolecule with a surface tension of 40 mN/m and an emulsification index of 96%, suggesting the production of a biosurfactant and bioemulsifier, respectively. The compounds showed glycolipid nature but the biosurfactant presented cationic charge, while the bioemulsifier, anionic charge. Thus, the results confirmed that M. hiemalis produced two distinct biomolecules under different parameters and in the same culture medium. CONCLUSIONS: It is the first time that biosurfactant and emulsifier production has been described in the same medium and under different physical conditions by Mucor hiemalis. Both biomolecules showed thermal stability, as well as have significant effect on the viscosity of hydrophobic compounds, indicating the excellent potential for environmental safety or industrial applications to improve the efficiency of sustainable and economic technologies.

Desarrollo de vectores génicos basados en polímeros sintéticos: PEI y PDMAEMA / Development of genetic vectors based on synthetic polymers: PEI and PDMAEMA

RESUMEN En años recientes hubo un auge del uso de terapias génicas para el tratamiento de enfermedades de gran incidencia, como el cáncer. Generalmente, estas se basan en la liberación de material genético como plásmidos, en el núcleo celular, con lo cual se corrige una función o se induce la producción de proteínas deficientes a nivel fisiológico. Para llevar a cabo la terapia génica se requiere de vectores capaces de encapsular el material genético y garantizar su entrega en el núcleo celular. Los polímeros catiónicos sintéticos han llamado la atención como vectores, debido a su capacidad de condensar ácidos nucleicos para formar partículas que los protegen de la degradación enzimática y facilitan su captación celular. La polietilenimina y el polimetacrilato de N, N-dimetilaminoetilo son los polímeros catiónicos más eficaces para la administración génica. Sin embargo, estos requieren modificaciones químicas específicas para eliminar o disminuir algunas limitaciones tales como su alta citotoxicidad y baja biodegradabilidad. En este artículo se analizan algunas de estas modificaciones, enfocándose en avances recientes en el desarrollo de copolímeros anfifílicos como precursores de nanopartículas usadas como vectores génicos.

SUMMARY During recent years, the use of genetic therapies has taken relevance in the treatment of high-incidence diseases such as cancer. Usually, they are based on the release of genetic material, as plasmids, into the cell nucleus, which corrects a function or induces the production of a deficient protein at the physiological level. To carry out gene therapy, vectors capable of encapsulating the genetic material and guaranteeing its delivery in the target cell nucleus are required. Synthetic cationic polymers have attracted great attention as vectors due to their ability to condense nucleic acids to form particles that protect them from enzymatic degradation and facilitate their cellular uptake. Polyethylenimine and poly (N, N-dimethylaminoethyl methacrylate) are the most effective cationic polymers for gene delivery. However, these polymers require specific chemical modifications to either avoid or diminish their high cytotoxicity and low biodegradability. This review analyzes some of these modifications, focusing on recent advances in the development of amphiphilic copolymers as precursors of nanoparticles used as gene vectors.

Research Progress of Liquid Crystalline Nanoparticles as Drug Delivery System / 中国药学杂志

Liquid crystalline nanoparticles are composed of a certain concentration of amphiphilic lipid self-assembly in water. The attractiveness of this formulation is linked to the nanostructural versatility, compatiblity, digestiblity and bioadhesive properties of their lipid constituents, and the capability of solubilizing and sustaining the release of amphiphilic, hydrophobic and hydrophilic drugs. Liquid crystalline nanoparticles, as a novel drug delivery system, have great promise in drug delivery. The carrier materials, preparation methods, characterization and applications of liquid crystalline nanoparticles were reviewed based on relevant articles published in recent years to provide reference for further study of liquid crystal nanoparticles.

New Carrier Materials for Particles Drug Delivery System of Irinotecan Hydrochloride / 中国药学杂志

OBJECTIVE: To prepare micelle drug delivery system of irinotecan hydrochloride, which could reduce its side effects and improve the therapeutic effects. METHODS: Firstly, the irinotecan hydrochloride was prepared as phospholipid compound to improve the lipophilicity. The synthesized polycaprolactone-polyethylene glycol copolymer was used as carrier material, then the phospholipid complex of irinotecan hydrochloride was wrapped to prepare a polymer micelle drug delivery system. The optimum prescription and preparation process of micelle drug delivery system of irinotecan hydrochloride were screened by the method of single factor combined with orthogonal test. RESULTS: The liposoluble of phospholipid compound of irinotecan hydrochloride was obviously increased compared with active compound. The irinotecan hydrochloride micelle was spherical and its particle size distribution was uniform. The average entrapment efficiency was 61.32%, and the average drug loading was 2.88%. CONCLUSION: Through this method, the particle size of irinotecan hydrochloride is small and the quality is controllable, and it is hopeful to increase the drug concentration at the target site.

Desenvolvimento de vesículas poliméricas de poli(etileno glicol)-b-poli(ε-caprolactona) (PEG-PCL) para veiculação de L-asparaginase / Development of polyethylene glycol-polycaprolactone polymer vesicles for L-Asparaginase

A L-Asparaginase (ASNase) é um importante agente quimioterapêutico utilizado para o tratamento da leucemia linfoblástica aguda (ALL) há mais de 40 anos. No entanto, devido à origem biológica da ASNase, enzima produzida por Escherichia coli, problemas como a imunogenicidade e baixa meia vida-plasmática devem ser considerados. Com o objetivo de minimizar essas desvantagens, várias ASNases homólogas bem como formulações de ASNase de E. coli foram investigadas. Nenhuma das formulações desenvolvidas, entretanto, foi capaz de resolver definitivamente esses problemas associados à sua origem. Nesse sentido, considerando os recentes avanços na ciência de polímeros com a possibilidade do obtenção de vesículas poliméricas usando copolímeros, este trabalho concentrou-se no desenvolvimento de polimerossomos de poli(etileno glicol)-b-poli(ε-caprolactona) (PEG-PCL) para encapsular a ASNase. Diversas condições experimentais foram investigadas e, ao final, os polimerossomos foram produzidos pela técnica de hidratação do filme polimérico utilizando a centrifugação como técnica de pós-filme para remoção de copolímero precipitado, produzindo assim vesículas polímericas de 120 a 200nm com PDI de aproximadamente 0,250. A eficiência de encapsulação da ASNase, utilizando as metodologias de centrifugação ou cromatografia de exclusão molecular, revelou taxas de encapsulação de 20-25% e 1 a 7%, repectivamente. Esses resultados apontam a importância de se determinar a eficiência de encapsulação por cromatografia de exclusão molecular ou método direto no caso de nanoestruturas auto-agregadas formadas por copolímeros, devido a valores superestimados com o emprego da centrifugação. Ainda que estudos complementares se façam necessários para liberação da enzima encapsulada ou penetração da L-asparagina nas vesículas, nossos resultados demonstram o potencial de polimerossomos para veiculação de ASNase, bem como de outras proteínas terapêuticas

L-Asparaginase (ASNase) is an important chemotherapeutic agent used for the treatment of acute lymphoblastic leukemia (ALL) for more than 40 years. However, due to the biological origin of ASNase (produced by Escherichia coli) some drawbacks such as immunogenicity and low plasma half life are present. In order to minimize the disadvantages, several ASNases proteoforms and formulations of E. coli ASNase were investigated. However, none of this formulations completely solved the main drawbacks of ASNase. In this sense, considering the recents advances in polymers science with the possibility to develop polymeric vesicles using copolymers, this work aimed at the development of poly(ethylene glycol)-b-poly(ε-caprolactone) (PEG-PCL) vesicles to encapsulate ASNase. Different experimental conditions were investigated and, the final polymersomes formulation was prepared by film hydratation using centrifugation as a post-film technique to remove the bulky coplymer. Polymeric vesicles of 120 to 200nm with PDI of approximately, 0.250 were obtained. The encapsulation efficiency of ASNase was determined indirectly by centrifugation and directly by size exclusion chromatography, resulting in encapsulation rates of 20-25% and 1 to 7%, respectively. These results indicate the importance of determining the efficiency of encapsulation by size exclusion chromatography or direct method in the case of self-aggregated nanostructures formed by copolymers, due to values overestimated with the use of centrifugation. Our results point to the potential of polymersomes for ASNase delivery, as well as other therapeutic proteins. Nonetheless, complimentary studies are still necessary for ASNase release or L-asparagine penetration into the vesicles

Desenvolvimento e caracterização de polimerossomos para veiculação de L-asparaginase / Development and characterization of polymersomes for the release of L-asparaginase

A enzima L-Asparaginase (ASNase) é um biofámaco utilizado no tratamento da leucemia linfoblástica aguda, no entanto, a evolução da produção da ASNase como um medicamento desde o final da década de 1970 resultou em apenas quatro alternativas disponíveis no mercado farmacêutico, com relatos de graves reações imunogênicas e toxicidade. Desse modo, a nanotecnologia é uma plataforma que pode ser explorada para administração dessa enzima diminuindo a exposição da mesma a proteases e aumentando a sua meia-vida aparente. Os polimerossomos (PL) são opções que pela nanoestrutura vesicular poderiam encapsular a ASNase em seu core aquoso e pela presença de uma membrana polimérica, são mais robustos que os lipossomos. Assim, neste trabalho objetivou-se desenvolver PL para encapsulação da ASNase como uma alternativa às formulações deste biofármaco existentes. Foram desenvolvidos PL de PEG-PLA, PMPC-PDPA, PEG-PDPA e Pluronic® L-21. Foram estudados fatores relacionados à composição dos copolímeros (fração hidrofílica, responsividade a fatores externos tais como pH e temperatura) e métodos de elaboração (hidratação do filme polimérico, troca de pH e temperatura) bem como foi feita a caracterização dos PL obtidos (tamanho, índice de polidispersão, espessura de membrana, formação de excessivo bulk polimérico, obtenção de micelas). Também foi feito um planejamento racional para encapsulação da ASNase (hidratação direta do filme polimérico e encapsulação por eletroporação, autoagregação com encapsulação por troca de pH ou de temperatura). Para os PL preparados com PEG-PLA, a extrusão resultou em distribuição de tamanhos mais estreitos correspondentes aos valores de PDI de 0,345, 0,144 e 0,081 para PEG45-PLA69, PEG114-PLA153 e PEG114-PLA180, respectivamente. Foi demonstrado que copolímeros com menor fração hidrofóbica resultam em maior eficiência de encapsulação para proteínas, já que possuem volumes aquosos maiores. Com o PMPC25-PDPA72 foi possível encapsular em média três unidades de ASNase por vesículas através da eletroporação ou troca de pH, sendo que no primeiro método houve formação de túbulos e no último método as micelas não foram completamente removidas. Para PEG100-PDPA80, grandes agregados permaneceram após a purificação levando a um PDI alto, mas não foi observada a formação de túbulos, já a troca de pH para este copolímero resultou em maior perda de copolímeros como bulk polimérico precipitado. Para o copolimero tribloco Pluronic® L-121, foi observado que as vesículas eram estáveis durante uma semana à temperatura ambiente, contrariando o que era descrito na literatura. Nesses sistemas, quando preparados por hidratação do filme, a encapsulação da ASNase foi realizada por eletroporação mas a proteína não foi detectada dentro das vesículas. Atribuímos a não-encapsulação à organização da bicamada Pluronic® L-121 sem conformação definida das cadeias poliméricas, dificultando a reorganização do bloco hidrofílico na porção interna do poro durante eletroporação. Por troca de temperatura, cerca de 5 % de ASNase foi encapsulada e o método resultou em total recuperação da atividade da enzima. Desse modo foram obtidos diferentes PL com diferentes características nanoestruturais de acordo com os copolímeros utilizados para carreamento da ASNase

The enzyme L-Asparaginase (ASNase) is a biopharmaceutical used in the treatment of acute lymphoblastic leukemia, still the industrial production of ASNase as a marketable drug since the late 1970s has resulted in only four alternatives available in the pharmaceutical market, with reports of severe immunogenic reactions and toxicity. In this sense, nanotechnology is a platform that can be exploited to administer this enzyme by decreasing its exposure to proteases and increasing its apparent half-life. Polymerosomes (PL) are interesting routes which by its intrinsically vesicular nanostructure could encapsulate the ASNase in its aqueous core and by the presence of a polymeric membrane, being more robust than the liposomes. Thus, in this work it was intended to develop PL for ASNase encapsulation as an alternative to existing formulations of this biopharmaceutical. PL of PEG-PLA, PMPC-PDPA, PEG-PDPA and Pluronic® L-21 were developed. It was studied the copolymers composition (i.e. hydrophilic fraction, responsiveness to external factors such as pH and temperature), PL design (i.e. polymer film hydration, pH change and temperature) and PL characterization (i.e. size, polydispersity index - PDI, membrane thickness, formation of excessive polymer bulk, micelles production). A suitable experimental planning for ASNase encapsulation (i.e. direct hydration of the polymeric film and encapsulation by electroporation, self-aggregation with encapsulation by pH or temperature change) was also performed. For the PL prepared with PEG-PLA, the extrusion resulted in narrower size distribution corresponding to the PDI values of 0.345, 0.144 and 0.081 for PEG45-PLA69, PEG114-PLA153 and PEG114-PLA180, respectively. It has been shown that copolymers with lower hydrophobic fraction result in higher encapsulation efficiency for proteins, since they have larger aqueous volumes. With PMPC25-PDPA72 PL, it was possible to encapsulate three units of ASNase per vesicles through electroporation or pH change. In the first method, tubules were formed and in the latter one the micelles were not completely removed. For PEO100-PDPA80 PL, large aggregates remained after purification leading to a high PDI value, nevertheless no tubule formation was observed, since the pH change for this copolymer resulted in greater loss of copolymers as a precipitated polymer bulk. For the Pluronic® L-121 triblock copolymer PL, it was observed that the vesicles were stable for one week at room temperature, contrary to what was described in the literature. These PLs were prepared by film hydration method and ASNase encapsulation was performed by electroporation, nonetheless the protein was not detected within the vesicles. It is attributed the non-encapsulation to the organization of the Pluronic® L-121 bilayer without defined conformation of the polymer chains, making it difficult to reorganize the hydrophilic block in the internal portion of the pore during electroporation. By temperature change, about 5% of ASNase was encapsulated and the method resulted in complete recovery of enzyme activity. In conclusion, several PLs with a vast range of differential nanostructural characteristics were obtained according to the copolymers used for ASNase loading

Enhancing thermal stability of glucose oxidase by fusing amphiphilic short peptide / 生物工程学报

Glucose oxidase catalyzes the oxidation of β-D-glucose to gluconic acid and its derivatives, thus shows a great potential in the development of antibiotic-free feed. However, its production and processing still have the problem of poor thermal stability of enzyme activity. In this study, fusion of amphiphilic peptide technology was used to improve the stability of glucose oxidase. Herein, eight self-assembling peptides with different amino acid lengths and Linkers were fused to the N terminus of the glucose oxidase, yielding eight chimeric fusions SAP1-GS-GOD, SAP1-PT-GOD, SAP2-PT-GOD, SAP3-PT-GOD, SAP4-PT-GOD, SAP5-PT-GOD, SAP6-PT-GOD and SAP7-PT-GOD. Then, the 8 recombinant proteins were expressed in P. pastoris GS115. After separation and purification, the stability of glucose oxidase at 60 ℃was determined. The relative enzyme activities of the PT Linker-linked fusion enzyme incubated at 60 ℃ for 60 min were higher than those of the original enzyme, and the relative activity of SAP5-PT-GOD was 67% at 60 ℃ for 30 min, which was 10.9 times higher than that of the initial enzyme with the same treatment. Among them, the Kcat/Km value of SAP1-PT-GOD, SAP2-PT-GOD, SAP3-PT-GOD and SAP5-PT-GOD of the fusion enzyme was further improved than that of the initial enzyme. Through the analysis of the intramolecular force of the fusion enzyme, the increase of the thermal stability of the fusion enzyme is mainly due to the increase of the hydrogen bond. In summary, the study indicates that translational fusion of self-assembling peptides with PT Linker was able to augment the thermo-stability of glucose oxidase, which has certain potential in the production and application of glucose oxidase. The glucose oxidase with improved thermostability obtained in the above study and the related mechanism will play an important role in improving the activity of related enzymes in the proceeding of processing and application.

Thermoresponsive and Biodegradable Amphiphilic Block Copolymers with Pendant Functional Groups

BACKGROUND: To develop the biodegradability and thermoresponsive hydrogel, in this work we designed a pendant-functionalized, thermoresponsive, amphiphilic block copolymer. METHODS: Methoxy poly(ethylene glycol) (MPEG)-b-[poly(ε-caprolactone)-ran-poly(ε-caprolactone-3-one)-ran-polylactic acid] (MCL) and (MPEG-b-[PCL-ran-POD-ran-PLA]) [MCL-(CO)] block copolymers were prepared by ringopening polymerization of ε-caprolactone, OD and lactide monomers. The subsequent derivatization of MCL-(CO) provided MPEG-b-[PCL-ran-poly(ε-caprolactone-3-COOH)-ran-PLA] [MCL-(COOH)] with COOH pendant groups and MPEG-b-[PCL-ran-poly(ε-caprolactone-3-NH2)-ran-PLA] [MCL-(NH2)] with NH2 pendant groups. RESULTS: The measured segment ratios of MCL-(CO), MCL-(COOH), and MCL-(NH2) agreed well with the target ratios. The abundances of the COOH and NH2 groups in the MCL-(COOH) and MCL-(NH2) copolymers were determined by 1H- and 13C-nuclear magnetic resonance spectroscopy, and agreed well with the target abundances. MCL-(CO), MCL-(COOH), and MCL-(NH2) formed homogeneous, white, opaque emulsions at room temperature. Rheological analysis of the block copolymer suspensions indicated a solution-to-hydrogel phase transition as a function of temperature. The solution-to-hydrogel phase transitions and the biodegradation of MCL-(CO), MCL-(COOH), and MCL-(NH2) were affected by varying the type (ketone, COOH, or NH2) and abundance of the pendant groups. CONCLUSION: MCL-(CO), MCL-(COOH), and MCL-(NH2) with ketone, COOH, and NH2 pendant groups showed solution-to-hydrogel phase transitions and biodegradation behaviors that depended on both the type and number of pendant groups.

Biosurfactant production by fungi as a sustainable alternative / Produção de biossurfactantes por fungos como uma alternativa sustentável

A wide variety of bacteria is far more exploited than fungi as biosurfactants (BS) or bioemulsifiers (BE), using renewable sources. BS are considered to be environmentally safe and offer advantages over synthetic surfactants. However, the BS yield depends largely on the metabolic pathways of the microorganisms and the nutritional medium. The production of BS or BE uses several cultural conditions, in which a small change in carbon and nitrogen sources affects the quantity of BS or BE produced. The type and quantity of microbial BS or BE produced depend mainly on the producer organism, and factors such as carbon and nitrogen sources, trace elements, temperature and aeration. The diversity of BS or BE makes it interesting to apply them in the pharmaceutical and cosmetics industries, agriculture, public health, food processes, detergents, when treating oily residues, environmental pollution control and bioremediation. Thus, this paper reviews and addresses the biotechnological potential of yeasts and filamentous fungi for producing, characterizing and applying BS or BE.(AU)

Uma grande variedade de espécies bacterianas é bem mais explorada que os fungos como agentes biossurfactantes (BS) ou bioemulsificantes (BE), usando fontes renováveis. Os BS são considerados ecologicamente seguros e oferecem vantagens sobre os surfactantes sintéticos. Entretanto o rendimento de BS depende grandemente das vias metabólicas dos micro-organismos e do meio nutricional. A produção de BS ou BE utiliza várias condições culturais, em que uma pequena alteração nas fontes de carbono e nitrogênio afeta a produção de BS. O tipo e a quantidade de BS ou BE microbianos produzidos dependem principalmente do organismo produtor e de fatores como fontes de carbono e nitrogênio, oligoelementos, temperatura e aeração. A diversidade de BS ou BE torna-os interessantes para aplicação nos campos farmacêutico, cosmético, da agricultura, da saúde pública, em processos alimentares, detergentes, no tratamento de resíduos oleosos, no controle de poluição ambiental e na biorremediação. Assim, a presente revisão aborda o potencial biotecnológico de leveduras e fungos filamentosos para produção, caracterização e aplicações de BS ou BE.(AU)

Preparation and in vitro studies of polysaccharide modified compound liposomes loaded with paclitaxel and doxorubicin / 中国药科大学学报

The objectives of this study were to prepare polysaccharide modified compound liposomes loaded with paclitaxel (PTX) and doxorubicin (DOX) and characterize their phyisicochemical properties,stability and in vitro release profiles.Both PTX-DOX-Lipo and N-lauryl-O-glycol chitosan (LGC) modified liposomes (PTX-DOX-Lipo-LGC) were successfully prepared,and the morphology of the liposomes was observed by transmission electron microscope (TEM),and particle size and zeta potential were analyzed by dynamic light scattering (DLS).pH and osmotic pressure were also determined.The drug loading and encapsulation efficiency,stability and in vitro release were assayed using high-performance liquid phase.Both PTX-DOX-Lipo and PTX-DOX-Lipo-LGC exhibited spherical shape with smooth surface.The average diameter was about 150 nm.pH value and osmotic pressure were in the range of 5.3-6.1 and 820-870 mOsm/kg,respectively.Both PTX and DOX could be encapsulated in liposomes with high encapsulation efficiency (greater than 90％).Compared with PTX-DOX-Lipo,PTX-DOX-Lipo-LGC exhibited lower leakage,higher stability in serum and more sustained release profiles.Moreover,a quicker release rate was observed in pH 5.8 PBS compared with pH 7.4 PBS.PTX-DOX-Lipo-LGC with high drug loading,good stability and sustained drug release profiles has a wide prospect in future clinical application.

Study on compatibility of self-assembled gel containing RGD amphipathic peptide with bone marrow mesenchymal stem cells / 重庆医学

Objective To analyze the compatibility of bone marrow mesenchymal stem cells (BMSCs) with amphiphilic peptide three-dimensional gel.Methods Three healthy 3-week old SD rats were taken for separating femur and tibia to obtain BMSCs,the BMSCs surface antigen was detected by flow cytometry;the 10 mg/mL RGD-cyclic amphiphilic peptide solution was added into the same volume of DMEM/F12 culture medium,after a few seconds,which was self assemble into three-dimensional gel.Three dimensional gel structure was observed by transmission electron microscope (TEM).1 × 106 cells/mL BMSCs suspension and RGDcyclic amphiphilic peptide were mixed to form a 3D culture system,1 × 106 cells/mL BMSCs suspension was mixed with polylysine to form a 2D culture system,the serum-free culture was conducted;the CCK-8 method was used to observe the cell growth situation,calcein acetoxy methyl ester/propidium iodide (PI) double standard staining was performed.The effect of RGD-cyclic amphiphilic peptide on the proliferation of BMSCs was observed by fluorescence microscopy.Results The separated and cultured BMSCs highly expressed CD29 and CD90,but lowly expressed or did not express CD34 and CD45;TEM showed that the gel was composed of multiple empty nanofibers with the nanofiber diameter of 2-5 nm and length of 100-1 000 nm;the molecular weight of synthetic peptides detected by mass spectrometry (MS) was 1 256.37,which was consistent with the theoretical value;the HPLC analysis showed that RGD-amphiphilic peptide purity was 95.88 ％;the calcein acetoxyl methyl ester/PI double staining showed that in the 3D culture system,a few BMSCs died after 30 min and the cells began to proliferate after 12 h,the proliferation was more active than that of 2D culture,and the difference was statistically significant (P＜0.05);CCK-8 cell count showed that the proliferation activity of 3D culture system was higher than that of 2D culture system,and the difference was statistically significant (P＜0.05).Conclusion RGD amphiphilic peptide has a good biocompatibility with BMSCs,and may become the tissue engineering scaffold material.

Preparation and quality evaluation of comet-shaped hydroxy camptothecin-loaded amphiphilic block copolymer / 药学学报

In this study, we used Shirasu porous glass membrane (SPG) as a template and hydroxy camptothecin (HCPT) as a model drug to prepare the comet-shaped MePEG[methoxyl poly(ethylene glycol)]-PLGA[poly(lactic-co-glycolic acid)-HCPT amphiphilic block copolymer. Our method was optimized by the orthogonal design method. The partical size, zeta potential, drug-loaded content, yield, shape and status of the obtained comet-shaped MePEG-PLGA-HCPT particles were further characterized by dynamic light scattering (DLS), scanning electron microscopy (SEM)/transmission electron microscopy (TEM), X-ray diffraction (XRD) and differential scanning calorimetry (DSC) et al, respectively. In vitro release was preliminary evaluated. MTT assay to preliminary evaluate the cytotoxicity of particles against human liver BEL-7402 cells. Based on these experimental results, the optimal preparation conditions contain:weight ratio of HCPT to MePEG-PLGA was 1:1, nitrogen pressure was 100 kPa and SPG membrane pore size was 1.1 μm. The particles exhibited a comet-shaped shape, fairly uniform size and were well dispersed. The drug-loading content was 46.2%, with yield of 96.4%, and zeta -31.4 mV. The distribution of HCPT in particles was very uniform, and HCPT showed a amorphous state existed in particles. The release behavior in vitro showed sustained releasing,and with the drug loading content in proportion to the release of the drug. MTT test indicated that the HCPT-loaded comet-shaped particles had enhanced the cytotoxicity against human liver BEL-7402 cells relatively to the HCPT-loaded spherical particles in vitro. The results showed a promising potential application of the preparation in clinical treatment of tumor.

Partition-Optimized Single Emulsion Particles Improve Sustained Release of Amphiphilic Bumped Kinase Inhibitors to Control Malaria Transmission.

Amphiphilic molecules are challenging to be incorporated into polymeric particles for sustained release due to their significant solubility in both water and organic solvent used in the fabrication process. Here, we investigated an extensive panel of fabrication methods for the incorporation and release of amphiphilic molecules, in particular, novel amphiphilic bumped kinase inhibitors (BKIs). Previously, BKIs were shown to reduce malaria transmission by blocking of gametocyte exflagellation. Prolonged BKI bioavailability for effective transmission blocking is crucial since infectious gametocytes circulate for several weeks in the mammalian host, well beyond the half-life of BKIs. So far, delivery systems for sustained release of those BKIs have not been successfully formulated yet. Here we demonstrate that out of several delivery vehicles the partition-optimized single emulsion particles are the ideal system for incorporation and sustained release of amphiphilic BKIs. They increased the incorporation greater than 90% through optimized partitioning of amphiphilic molecules to the polymer phase and sustained release of BKIs up to several weeks with a reduction in the initial burst release. Overall this work provides a method for the incorporation and sustained release of amphiphilic BKIs, and can be adapted for other amphiphilic molecules.

Effects of the amphiphilic peptides on membrane permeability of Acinetobacter baumannii / 重庆医学

Objective To investigate effects of the amphiphilic peptides on membrane permeability of acinetobacter bauman-nii .Methods The LysAB3 and LysAB3-D (lack of amphiphilic peptides structure gene) was synthesized and inserted into the vec-tor pET28a(+ ) to construct the recombinant expression plasmid (pET28a-LysAB3 ,pET28a-LysAB3-D) .After expression in E . coli BL21(DE3) and purification with Ni2+-NTA Sepharose .Acinetobacter baumannii was observed by scanning electron microsco-py and fluorescence microscope ,pretreated with LysAB3 and LysAB3-D respectively .Results Under scanning electron microscopy , LysAB3-treated acinetobacter baumannii exhibited not only significant abnormalities ,including deep roughening of the cell surface , but also FITC readily accumulated in bacteria .It was different from LysAB3-D-treated .Conclusion These results indicate that the amphiphilic peptides structure increase membrane permeability of acinetobacter baumannii ,which helps LysAB3 degrade bacteria .

Determination of Plant Hormones by Capillary Electrophoresis Based on Polymer Micelles / 分析化学

With the increasing number of food safety problems caused by the abusing and misusing of plant hormones, it will be increasingly important to strengthen the trace detection of plant hormones in foods. In this study, benzyl methacrylate_methyl methacrylate_based amphiphilic polymer micelles were prepared, and a method for trace determination of five plant hormones was established by using these micelles. This method was rapid, sensitive and reproducible. Through optimization, the best experimental conditions were obtained as follows: 2 g/L polymer micelles, 50 mmol/L NaOH_H3BO3 buffer (pH 9. 2), 15 kV running voltage. Based on this novel method, naphthalene acetic acid in the solution of rooting powder was determined.

Pharmacokinetics and tissue distribution of mitomycin amphiphilic chitosan polymeric micelles in rats / 中国药学杂志

OBJECTIVE: To investigate the pharmacokinetics and tissue distribution of mitomycin amphiphilic chitosan polymeric micelles (MMC-ACPM) in rats. METHODS: Mitomycin injection (MMC-INJ) and MMC-ACPM were administered to rats through tail vein at the dosage of 0. 5 mg · kg-1. An ultra-fast liquid chromatography with tandem mass spectrometry (UPLC-MS/MS) method was established to determine the concentration of mitomycin (MMC) in plasma and tissues of rats. RESULTS: The t1/2(β) of MMC-INJ and MMC-ACPM in plasma were estimated to be (0.67 ± 0.36) and (3.33 ± 1.47) h, respectively. The AUC0→∞ were calculated to be (120.94 ± 13.77) and (140.95 ± 11.56) ng · mL-1 · h-1, respectively. The MRT were (0.83 ±0.13) and (1.56 ± 0.22) h, and CL were (0.005 ± 0.001) and (0.003 ± 0.001) L · h-1 · kg-1, respectively. Compared with MMC-INJ group, MMC-ACPM group had lower concentrations of MMC in heart, liver, spleen, lung, and kidney of rats. CONCLUSION: MMC-ACPM can prolong the circulation of MMC in vivo, improve its bioavailability, and reduce the accumulation in liver and kidney, which can improve curative effects and reduce toxicity.